Gainers
- AVEO Pharmaceuticals, Inc. AVEO shares jumped 89.1% to close at $15.28 on Wednesday as the company confirmed the FDA approval of FOTIVDA for relapsed, refractory advanced renal cell carcinoma.
- Koss Corporation KOSS shares surged 69.2% to close at $30.28 on Wednesday.
- Enveric Biosciences, Inc. ENVB shares jumped 55% to close at $4.54 on Wednesday in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech. It is a biopharmaceutical company focused on developing new molecules for oncology.
- Roblox Corporation RBLX surged 54.4% to close at $69.50 after the company priced its IPO at $45 per share.
- MediciNova, Inc. MNOV shares gained 53.9% to close at $8.74 after the biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical countermeasure against lung damage induced by chlorine gas.
- New Concept Energy, Inc. GBR gained 45% to close at $6.61.
- Talend S.A. TLND rose 27.5% to close at $65.40 after Private equity investment firm Thoma Bravo inked a memorandum of understanding (MoU) with data integration and data integrity provider Talend to acquire it for $2.4 billion or $66 per share, signifying a 29% premium to Talend’s closing price of $51.30 on March 9.
- Express, Inc. EXPR rose 25.7% to close at $4.25 after the company reported better-than-expected fourth-quarter results.
- Affimed N.V. AFMD jumped 23.8% to close at $6.77 after the company announced the continuation of its REDIRECT study of AFM13 in PTCL.
- Alimera Sciences, Inc. ALIM surged 23.3% to close at $9.27.
- Build-A-Bear Workshop, Inc. BBW gained 22.6% to close at $8.75 after the company reported better-than-expected Q4 results.
- Sino-Global Shipping America, Ltd. SINO shares surged 21.5% to close at $6.72.
- Martin Midstream Partners L.P. MMLP jumped 19.6% to close at $2.93.
- Inari Medical, Inc. NARI climbed 19.1% to close at $118.27 after the company reported better-than-expected Q4 results and issued strong revenue guidance.
- ImmunityBio Inc. IBRX gained 19.1% to close at $38.70. The company begun trading on Nasdaq following merger with NantKwest.
- Evofem Biosciences, Inc. EVFM gained 18.9% to close at $2.70. Evofem Biosciences, last week, reported worse-than-expected Q4 EPS.
- Earthstone Energy, Inc. ESTE surged 18.9% to close at $8.54.
- AirNet Technology Inc. ANTE jumped 18.7% to close at $4.19.
- Transocean Ltd. RIG shares gained 18.5% to close at $4.68.
- Stable Road Acquisition Corp. SRAC jumped 18.3% to close at $15.87.
- United Natural Foods, Inc. UNFI surged 18.2% to close at $36.06 after the company reported better-than-expected Q4 earnings.
- Riley Exploration Permian, Inc. REPX rose 18.2% to close at $24.23. Bluescape Riley Exploration recently reported a 32.9% stake in Riley Exploration Permian.
- Boxlight Corporation BOXL gained 17.6% to close at $2.61.
- Barnwell Industries, Inc. BRN surged 17.5% to close at $3.15.
- Atossa Therapeutics, Inc. ATOS shares rose 17.3% to close at $2.91 after gaining over 16% on Tuesday. Atossa Therapeutics, last month, announced final results from its Phase 1 study evaluating AT-301 administered by nasal spray. AT-301 is being developed for at-home use for patients recently diagnosed with COVID-19..
- SIFCO Industries, Inc. SIF surged 17.2% to close at $10.48.
- Star Peak Energy Transition Corp. STPK gained 17.2% to close at $31.14.
- Navios Maritime Holdings Inc. NM surged 16.3% to close at $7.85.
- Talis Biomedical Corporation TLIS jumped 15.9% to close at $14.79. ArrowMark Colorado Holdings LLC reported a 12.1% stake in Talis Biomedical.
- Vermilion Energy Inc. VET shares gained 15.7% to close at $8.40.
- Lizhi Inc. LIZI shares rose 15.5% to close at $7.90 on continued strength after the company on Tuesday reported better-than-expected Q4 results.
- Clean Energy Fuels Corp. CLNE gained 15.2% to close at $13.59 after the company reported better-than-expected Q4 results.
- REV Group, Inc. REVG climbed 13.7% to close at $16.06 after the company reported better-than-expected Q4 results.
- Barnes & Noble Education, Inc. BNED gained 12.9% to close at $8.06 after Needham maintained its Buy rating and raised its price target from $5 to $9 per share.
- Viant Technology Inc. DSP gained 10.7% to close at $43.80. Viant Technology, last month, priced its IPO at $25 per share.
- LAIX Inc. LAIX rose 10.7% to close at $3.00 after gaining around 16% on Tuesday.
- Lion Group Holding Ltd. LGHL rose 9.4% to close at $3.14after surging around 12% on Tuesday.
- CN Energy Group. Inc. CNEY shares rose 9.1% to close at $4.90. The company, last month, priced its IPO at $4 per share.
- Datasea Inc. DTSS surged 8.6% to close at $3.55.
- Biodesix, Inc. BDSX gained 8.5% to close at $20.14.
- ACADIA Pharmaceuticals Inc. ACAD gained 7.5% to close at $26.89. ACADIA Pharmaceuticals recently received a notification from the FDA indicating 'the FDA has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.'
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Just Energy Group Inc. JE shares tumbled 34.2% to close at $2.60 on Wednesday as the company said it received creditor protection under Chapter 15 of the Bankruptcy Code in the United States.
- INVO Bioscience, Inc. INVO fell 31.5% to close at $6.44. The company’s stock jumped 202% on Tuesday after the company said it has amended its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals.
- Sundance Energy Inc. SNDE fell 27.2% to close at $1.71 after the company announced that it would file for Chapter 11 Bankruptcy.
- MingZhu Logistics Holdings Limited YGMZ fell 26.8% to close at $5.40 after the company announced a $20 million registered direct offering.
- Second Sight Medical Products, Inc. EYES fell 24.9% to close at $11.63 after jumping over 31% on Tuesday. The company, on Friday, reported FDA approval for its Argus 2s Rentinal Prosthesis Systems.
- AnPac Bio-Medical Science Co., Ltd.ANPC fell 22.2% to close at $6.70. AnPac Bio-Medical Science shares jumped over 49% on Tuesday as the company said it has developed and completed evaluations for its CDA Pro Cancer Detection Sensor.
- TD Holdings, Inc. GLG fell 21.9% to close at $1.78.
- Sintx Technologies, Inc. SINT fell 20.9% to close at $2.27 after jumping 58% on Tuesday.
- Tupperware Brands Corporation TUP fell 19.9% to close at $25.96 after the company reported worse-than-expected Q4 results.
- MultiPlan Corporation MPLN dropped 19.7% to close at $6.25 after the company reported downbeat Q4 earnings.
- Vertex, Inc. VERX fell 19.6% to close at $25.13. Vertex posted upbeat Q4 results, but issued weak Q1 sales forecast.
- Anchiano Therapeutics Ltd. ANCN dipped 19% to close at $4.10.
- Espey Mfg. & Electronics Corp. ESP fell 17.3% to close at $15.25 after the company announced it suspended its quarterly dividend.
- Quidel Corporation QDEL dipped 16.6% to close at $130.01.
- Oragenics, Inc. OGEN fell 15.2% to close at $1.06. Oragenics shares jumped around 48% on Tuesday after announcing a deal related to its Terra CoV-2 vaccine candidate against COVID-19.
- Auris Medical Holding Ltd. EARS shares declined 14.6% to close at $4.44.
- New Oriental Education & Technology Group Inc. EDU dropped 14.1% to close at $159.75.
- Moxian, Inc. MOXC fell 13.4% to close at $2.14.
- Creative Realities, Inc. CREX dropped 12.5% to close at $1.89 following Q4 results.
- COMPASS Pathways plc CMPS fell 11.8% to close at $39.02. Compass Pathways recently posted a Q4 loss of $0.52 per share.
- TAL Education Group TAL dropped 11.6% to close at $66.93.
- Mohawk Group Holdings, Inc. MWK declined 11.1% to close at $32.42. Mohawk recently reported better-than-expected Q4 sales results.
- Brickell Biotech, Inc. BBI fell 9.8% to close at $1.10 after the company reported worse-than-expected Q4 earnings.
- Exela Technologies, Inc. XELA fell 9.5% to close at $4.17. Exela Technologies shares jumped 179% on Tuesday after the company said it won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in